Imidazolylpyrimidine compounds as HDAC and/or CDK inhibitors

Details for Australian Patent Application No. 2009271003 (hide)

Owner Gilead Sciences, Inc.

Inventors Venkataramani, Chandrasekar

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009271003

PCT Pub. Number WO2010/009139

Priority 61/080,426 14.07.08 US

Filing date 14 July 2009

Wipo publication date 21 January 2010

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2010/009139 Priority application(s): WO2010/009139

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009271007-Chipless table split screen feature

2009271001-Optimizing a seismic survey for source separation